In an adult with Clostridioides difficile-associated diarrhea after broad‑spectrum antibiotics, how can ileus be distinguished from toxic megacolon?

Distinguishing Ileus from Toxic Megacolon in C. difficile Infection

In fulminant C. difficile infection, ileus and toxic megacolon are both manifestations of severe disease that often coexist and are managed similarly with high-dose vancomycin (500 mg every 6 hours oral/enteral), IV metronidazole (500 mg every 8 hours), and rectal vancomycin (500 mg every 6 hours) if ileus is present 1, 2.

Key Clinical Distinctions

Toxic Megacolon

• Colonic dilation ≥6 cm (often >10 cm) on imaging, particularly affecting the transverse colon
• Systemic toxicity with fever, tachycardia, altered mental status
• Severe colonic inflammation with pseudomembrane formation visible on endoscopy
• Paradoxical decrease in diarrhea as the colon becomes atonic and dilated 3, 4

Ileus

• Paralytic bowel dysfunction affecting small and large intestine
• Absence of bowel sounds on examination
• Dilated bowel loops on imaging without the extreme colonic dilation seen in megacolon
• May present without diarrhea due to impaired intestinal motility 5

Critical Diagnostic Approach

Both conditions are defined as fulminant CDI when accompanied by hypotension/shock 1, 2. The practical distinction matters less than recognizing fulminant disease, as both require:

1. Immediate imaging (CT abdomen/pelvis) to assess:

   • Maximum colonic diameter (>6 cm suggests toxic megacolon)
   • Bowel wall thickening and pericolonic inflammation
   • Free air (perforation)
   • Ascites

2. Laboratory markers of severity:

   • WBC >15,000 cells/μL or <4,000 cells/μL
   • Creatinine >1.5× baseline
   • Lactate elevation
   • Albumin <2.5 g/dL 2, 6

3. Clinical signs:

   • Hypotension or shock
   • Altered mental status
   • Abdominal distension with tenderness
   • Decreased or absent bowel sounds

Common Pitfalls

The most dangerous pitfall is waiting for diarrhea to make the diagnosis—fulminant CDI can present with constipation or absent diarrhea when ileus or megacolon develops 5. A 2026 case report documented a patient with fulminant CDI mimicking acute colonic pseudo-obstruction without diarrhea, emphasizing that absence of diarrhea does not exclude severe CDI 5.

Another critical error is relying solely on toxin enzyme immunoassay—these tests have poor sensitivity in severe disease. A 2026 case demonstrated toxic megacolon with positive C. difficile antigen but negative toxin assay, requiring treatment based on clinical suspicion 7. When clinical suspicion is high with discordant testing, treat empirically 6.

Management Algorithm

Both ileus and toxic megacolon require identical aggressive medical therapy 1, 2:

• Vancomycin 500 mg every 6 hours (oral or via nasogastric tube)
• Metronidazole 500 mg IV every 8 hours
• Rectal vancomycin 500 mg every 6 hours (particularly important when ileus prevents oral medication from reaching the colon) 1, 2, 6

Immediate surgical consultation is mandatory, as colectomy may be life-saving. The 2026 AGA Clinical Practice Update emphasizes that fulminant CDI should be managed by a multidisciplinary team including gastroenterology, infectious disease, surgery, and critical care 6.

Do not use neostigmine if toxic megacolon is suspected, even if the presentation mimics acute colonic pseudo-obstruction—this can precipitate perforation 5.

Bottom Line

The distinction between ileus and toxic megacolon in CDI is less clinically relevant than recognizing fulminant disease (defined by hypotension/shock, ileus, or megacolon) 1, 2. Both require the same aggressive triple-therapy approach with high-dose vancomycin, IV metronidazole, and rectal vancomycin, along with immediate surgical consultation. Treat based on clinical presentation and imaging findings, not laboratory results alone 7, 6.